Halozyme is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer and rare diseases.
Business Model:
Revenue: $471.6M
Employees: 51-200
Address: 11388 Sorrento Valley Road
City: San Diego
State: CA
Zip: 92121
Country: US
Halozyme is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer and rare diseases.
Contact Phone:
+18587948889
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/6/2004
Ticker Symbol:
HALO
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2022 | Post-IPO Debt | $720M | 2/2019 | Post-IPO Equity | $0 |
arGEN-X arGEN-X arGEN-X arGEN-X |
8/2022 | Post-IPO Debt | $500M | 1/2016 | Post-IPO Debt | 2 | $150M |
Pharmakon Advisors Athyrium Capital Management LP Pharmakon Advisors Athyrium Capital Management LP |
1/2014 | Post-IPO Debt | 2 | $20M |
Oxford Finance LLC Silicon Valley Bank Oxford Finance LLC Silicon Valley Bank |
12/2013 | Post-IPO Debt | 2 | $30M |
Oxford Finance LLC Silicon Valley Bank Oxford Finance LLC Silicon Valley Bank |
5/2013 | IPO | - | 5/2020 | Post-IPO Equity | $0 |
Janssen Biotech Janssen Biotech Janssen Biotech Janssen Biotech |
2/2019 | Post-IPO Equity | 1 | $30M |
arGEN-X arGEN-X arGEN-X |
5/2013 | IPO | - |
|
5/2020 | Post-IPO Equity | 1 | $15M |
Janssen Biotech Janssen Biotech Janssen Biotech Janssen Biotech |
---|
Announced Date | Name | Price |
---|---|---|
4/2022 | Antares Pharma |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|